Showing results (2111-2120 of 2,970) with videos related to
Sort By:
Pageof 297
European Journal of Cancer (Oxford, England : 1990)|January 1, 2000
Antibodies raised by gastrimmune inhibit the spontaneous metastasis of a human colorectal tumour, AP5LVS A Watson, D Michaeli, T M Morris, et al.Nutrition and Cancer|December 7, 2002
Mutagenicity of food-derived carcinogens and the effect of antioxidant vitaminsBeverly A Montgomery, Jessica Murphy, James J Chen, et al.British Journal of Haematology|June 13, 2002
A novel inherited mutation of the transcription factor RUNX1 causes thrombocytopenia and may predispose to acute myeloid leukaemiaLogan C Walker, Jane Stevens, Hamish Campbell, et al.Nature|December 20, 2002
SAR11 clade dominates ocean surface bacterioplankton communitiesRobert M Morris, Michael S Rappé, Stephanie A Connon, et al.Cancer Genetics and Cytogenetics|January 1, 1983
Nonrandom cytogenetic changes in New Zealand patients with acute myeloid leukemiaP H Fitzgerald, C M Morris, G J Fraser, et al.Cancer Treatment Reviews|November 15, 2016
Approach to evaluation of fever in ambulatory cancer patients receiving chemotherapy: A systematic reviewM K Krzyzanowska, C Walker-Dilks, A M Morris, et al.CA: a Cancer Journal for Clinicians|October 12, 2016
The primary care provider (PCP)-cancer specialist relationship: A systematic review and mixed-methods meta-synthesisLesly A Dossett, Janella N Hudson, Arden M Morris, et al.Journal of the American College of Surgeons|May 27, 2008
Does surgeon case volume influence nonfatal adverse outcomes after rectal cancer resection?Kevin G Billingsley, Arden M Morris, Pamela Green, et al.Archives of Surgery (Chicago, Ill. : 1960)|January 17, 2007
Surgeon and hospital characteristics as predictors of major adverse outcomes following colon cancer surgery: understanding the volume-outcome relationshipKevin G Billingsley, Arden M Morris, Jason A Dominitz, et al.British Journal of Haematology|September 9, 2004
A randomized study (WOS MM1) comparing the oral regime Z-Dex (idarubicin and dexamethasone) with vincristine, adriamycin and dexamethasone as induction therapy for newly diagnosed patients with multiple myelomaG Cook, R E Clark, T C M Morris, et al.Pageof 297